2,456 Founder jobs in the United Kingdom

Job Post:  Domestic Service Electrician (Founder, Grade 3)

Location:  Bristol, Bath South Wales, Gloucester, Swindon

Employment Type:  Full Time Employment

About Us:

At MJP Electrical, our vision is to revolutionise our industry by providing world class client satisfaction whilst creating the best possible working environment for our team.

Position Overview:

We are looking to expand our team with skilled electricians for direct employment who have experience in domestic services. Join us to deliver top-quality electrical core services, including EICRs, EICR remedial works, emergency callouts, quick fixes, EV charging unit installations, consumer unit upgrades, re-wires, and quoting for works. This is an excellent chance to join a rapidly growing company that is making a significant impact.

We are on the lookout for talented individuals who are motivated to elevate their careers by becoming part of our fast and dynamic organisation. Join us and seize the potential for rapid advancement while playing a key role in delivering the outstanding service our clients depend on.

Key Responsibilities:

• Execute our systems and processes to over achieve our clients expectations
• Collaborate with our team to ensure optimal delivery of our services.
• Communicate effectively with customer support and our operations team.
• Maintain high standards of workmanship and professionalism whilst maintaining our excellent reputation.
• Provide feedback on with our leadership team on improvements of efficiency and all our core values.

Apply below and one of our team will reach out to you with next steps.

Job Types: Full-time

Pay: £30,000 - £40,000 per year

Expected hours: Full time (40 hours a week) Optional overtime available. Out of hours callout non mandatory and optional.

Requirements

Qualifications:

• Level 3 Award in Electrical Installations (18th Edition)
• C&G 2391 Inspection & Testing or 2394/5
• C&G 236 Part 1 & 2 or equivalent
• EV Charging 2921 - 2931 (preferred)
• NICEIC approved or equivalent (preferred)
• NAPIT accreditation (preferred)
• Solar 2399 -11 (preferred)

Experience & Knowledge:

• 5+ years as a qualified electrician

• EICR Assessments
• Fault finding
• Consumer unit upgrades
• House rewiring
• 3 phase light commercial (preferred)
• EV charging point installations (preferred)
• Solar (preferred)
• Testing
• Quoting
• Customer Service.
• Job management systems.
• Certification software (Icertify)
• Mentoring apprentices and newly qualified electricians.
• Experience in a domestic services environment
• Proven experience of supporting, motivating, and developing apprentices
• Experience in the service industry

Skills & Abilities:

• Proven ability to communicate confidently and effectively with a wide range of stakeholders
• Ability to build and support positive working relationships
• Proven problem-solving skills for electrical issues
• Confident IT skills, including use of Apple iPad and iPhone
• Excellent organisational skills
• Ability to follow policy and procedure

Personal Attributes:

• Enthusiastic and adaptable, dedicated to providing exceptional service
• Exhibit integrity when addressing sensitive matters
• Show respect for clients' properties
• Efficiently complete tasks with meticulous attention to detail
• Punctual and effective in managing time
• Well-organised
• Dependable and aligned with core values and high work standards
• Possess a positive attitude and a readiness to foster a collaborative team environment
• Passionate about personal and professional development
• Take pride in personal appearance
• Eager to train and mentor junior electricians

Other:

• Clean UK driving licence
• DBS clearance

Benefits

• Company van

• Company credit card
• Company events
• Goal setting
• Performance reviews
• Company pension
• Financial planning services
• Gym membership
• On-site parking
• Private medical insurance
• Overtime at 3/4 time standard rate
• Company Uniform
• Training and support

We're on the lookout for entrepreneurial individuals with technical and commercial domain expertise with keen interest in founding, and building a global scale, impact driven, high growth company from ground up.

We are seeking applications from experienced industry, startup and/or new science or engineering based technology development professionals from anywhere in the world to work with us on eliminating toxicity from agrochemicals, particularly pesticides.

You'll work closely with the DSV team, using our methodology , to spin-out a new company. During the programme, you’ll work on all aspects related to venture creation in this opportunity area, including working out the optimal approach to solve for the desired outcome, building a team and building a viable business case. Once the new venture is incorporated with pre-seed investment from DSV, you and your co-founders will own the majority stake in the business and continue receiving support from the DSV team post-spinout.

The role is full-time, remote initially until venture incorporation and spin-out (circa summer/autumn 2026), location TBD.

Conventional pesticides—spanning from neonicotinoids to atrazine—are a double-edged sword. They shield crops from pests but can wreak havoc beyond their targets. Pollinators like bees and butterflies, vital to 75% of global food crops, are in freefall—some bee populations have declined by over 43% in high-insecticide regions due to lethal and sublethal exposures that impair navigation, immunity, and reproduction. Pest resistance to widely used small molecules such as glyphosate and azoles is also a growing phenomenon, straining our available toolkit for safeguarding yields. This threatens both global food security and biodiversity. Beyond ecosystems, these chemicals can also cause acute intoxication, cancer, neurodegeneration, infertility, and hormonal disruptions in humans, driven by oxidative stress, DNA damage, and systemic inflammation - a problem being increasingly recognised especially in exposed rural populations. The transferability of these pesticides—spreading through soil, water, and trophic chains—amplifies their devastation, making sustainable alternatives non-negotiable.

Non-transferable pest controls have already shown scientific and commercial traction at the proof of concept level. For example, pheromone and other semiochemical approaches have shown success in disrupting pest mating patterns, while precision detection of weeds combined with electricide technologies is demonstrating some positive early trial data. However, the ability of non-transferrable pesticides to disrupt the incumbent agrochemical market remains relatively limited. Among the most important constraints in scaling adoption are high costs, coverage limitations, efficacy without affecting non-target species, and the risk of evolutionary ‘escape’. For example, Bacillus thuringiensis (‘Bt’) crops such as corn, cotton and soy - arguably the most prominent non-transferrable pesticide technology to date - have demonstrated a decline in efficacy after multiple growth seasons due to evolved resistance.

We imagine a future where we can protect crops without decimating ecosystems, collapsing food chains, or endangering human health. This is the vision driving our venture creation in this opportunity space: to halt ecological collapse and protect human health by reimagining pest control.

Our preliminary scoping of the area indicates high potential to develop approaches that meet our desired outcome: pest control that is scalable, durable, and effective without off-target effects. Emerging technologies, from RNAi silencing of pest genes through to engineered crop pheromone production, provide a set of promising tools that could provide the foundations for commercially viable propositions. However, each approach presents outstanding constraints that require solving. We believe that advances in diverse sectors, spanning from bioprocessing and genetic engineering through to GIS and precision agriculture tools, mean that it is the ideal time to tackle these barriers and we are looking for a Founder in Residence to take this on.

Requirements

This isn’t just a job—it’s a chance to realise your own vision for venture creation in this space. We need a visionary founder to lead this charge—someone who's a problem-solver with a passion for this opportunity area, comfortable working across multiple scientific disciplines, with a track record that broadly covers most of the following criteria:

• Deep knowledge of plant-pest interactions or pesticide development (e.g. PhD or equivalent industry R&D know-how focused genomics, molecular biology, entomology, plant pathology, virology and/or bacteriology);

• In-depth knowledge of state-of-the-art (SOTA) technologies and constraints in pest control, spanning from insecticidal proteins and RNAi through to precision chemical delivery and the implementation of IPM systems;
• A proven track record of bringing new biotech solutions/products/ventures from concept to market, ideally in agriculture/agrochemical industry;
• Broad understanding of the agrochemical industry, farmer needs, navigating regulatory frameworks (e.g., EPA, EU pesticide standards) and experience in forging partnerships with agricultural stakeholders is a big plus;
• Experience in raising funds from early-stage investors/VC is a big plus;
• A relentless passion to protect pollinators, ecosystems, and human health, with the leadership to drive own vision for venture creation in this space.

Benefits

By joining DSV, you will be part of a team of operators who have founded companies and led the translation of science at some of the most respected universities, charities, funds, and government agencies. Here’s what we offer:

• Access to optimised, purpose-built, proprietary tools, resources, and processes to help create high-impact ventures from scratch;
• Opportunity area-specific know-how from our network of Partners and Advisors;
• Up to £250k in investment to incorporate the new venture and develop early proof-of-concept data;
• Guaranteed income of £4,166 per month paid as a fixed consultancy fee until the company is launched and the pre-seed investment is secured;
• Majority equity stake in the new company between  you and your co-founder(s);
• Continuous post-spinout support, including fundraising, commercial partnerships, recruitment, and team-building;
• Collaborative support from dozens of Founders currently at DSV across sectors.

Deep Science Ventures (DSV) is on a mission to create a future in which both humans and the planet can thrive. We use our unique venture creation process to create, spin-out, and invest in science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures. Operating in four sectors—Pharmaceuticals, Climate, Agriculture, and Computation—we tackle the challenges defining these areas by taking a first principles approach and partnering with leading institutions.

Deep Science Ventures is creating a future in which both humans and the planet can thrive. We use our unique venture creation process to create, spin-out and invest into science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures. We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions.

Driven by mutual conviction in the huge unmet medical need in fibrotic diseases, DSV has partnered with General Inception to accelerate the development of novel therapeutics, jointly building a new venture solely dedicated to anti-fibrotic therapies. To maximise impact and exploit synergies across both organisations, we are forging a new venture creation model which combines DSV’s innovative first-principles venture creation methodology with General Inception’s deep domain expertise, network and portfolio - leveraging the best of both. 

To learn more about the partnership, please see our Press Release , and to learn more about General Inception

We are looking for future Founders: entrepreneurially-minded individuals with deep technical and commercial domain expertise, who are eager to solve urgent unmet challenges through venture building. This role offers a unique opportunity to work at the forefront of fibrosis drug development, solving challenges in protein engineering and myeloid reprogramming to reverse disease.

You will join DSV’s venture creation programme as a Founder-in-Residence and work closely with the DSV and GI team to spin out the new company. During the programme you will refine, improve and complement existing scoping work on:

• Prioritised therapeutic Approaches
• Clinical positioning
• Experimental PoC work plan & execution strategy
• Commercial neglect (IP strategy, differentiation, competition)
• Value proposition (market, value capture, techno-economics)
• Optimising for the most rapid and derisked path to Series A (less than 18-24 months from launch)

Preparation for investment decision committee will involve fulfilling any outstanding investment criteria, recruiting advisory and co-founding team members, and fundraising for additional expansion funds. 

Assuming success at both respective Investment Committees, you will receive pre-seed investment from DSV and GI, and spinout the company in early Q4 2025. You and your co-founders will own the majority stake in the business and continue receiving support post-spinout.

Fibrosis underlies a staggering proportion of human diseases, accounting for 18% of all global deaths (35% including solid tumours), with increasing prevalence worldwide, and consistent market growth across almost all indications. Yet there are still only two FDA-approved anti-fibrotic drugs – marketed for lung fibrosis alone – neither of which are able to meaningfully halt disease, let alone reverse it. 

The unmet medical need is therefore enormous. But competition in the development pipeline is increasingly fierce for liver and lung fibrosis, and many clinical approaches have historically proven to be intractable at reversing disease, teaching us valuable biological lessons that must be incorporated for the next generation of therapeutics. To reverse disease, we must directly or indirectly achieve multiple biological outcomes – manipulating pathogenic myofibroblasts, resolving pro-fibrotic inflammation, regenerating healthy epithelia & endothelia, degrading existing ECM deposits, and ideally neutralising (reactivity to) any upstream triggers. We believe we have identified approaches that may be able to address many if not all of these outcomes, by focussing on pro-resolution mechanisms and immune reprogramming.

Our ambition is to create impactful new medicines that have (i) transformative mono-therapeutic efficacy, (ii) applicability across multiple fibrotic diseases (beyond the lung), (iii) complementary yet distinct mechanism of action compared to standard-of-care medicines (to ensure combinability with future clinical regimens), and (iv)  conveniently and/or  infrequently administered (to ensure patient convenience and low burden on healthcare systems).

To this end, we want to pursue a multi-strategy portfolio of approaches that balance ambition, derisking, speed, and optionality, while maintaining focus on key biology areas where we can develop deep expertise and know-how. This will require a talented  expert in protein engineering and/or myeloid reprogramming to join the Founding team.

We believe now is the time to turn this vision into a reality. Will you join us to lead the effort?

Requirements

We are looking for an exceptional individual with the following:

Essential (must-have) 

• You have translational research experience in inflammatory/fibrotic disease at minimum PhD level;
• We are open to a wide range of profiles: from serial founders to first-time entrepreneurs, pharma experts, senior/principal scientists, innovative translational academics, and more;
• You have deep technical expertise in either: (1) myeloid cell biology, myeloid  reprogramming mechanisms, therapeutic myeloid targeting, AND/OR, (2) protein engineering, stabilisation & ligand binding modification, biologics development, protein miniaturisation for oral delivery, or generative AI protein design;
• You have 10+ years industry experience in pharma, biotech, academic drug discovery, or life sciences roles in VC, BD, and/or strategy consulting;
• You are highly motivated by unsolved challenges in fibrotic disease , and driven to challenge the status quo of how we treat them;
• You are impact driven , take the initiative, make things happen, and can think from a first principles perspective to figure out what’s really needed;
• You have clear entrepreneurial spirit and mindset , demonstrated through impactful innovation, and an ability to work in ambiguous, unstructured but fast-paced, demanding and pressurised environments;
• Collaborative nature , with the ability to work effectively in cross-functional teams.

Preferred (nice-to-have) 

• Previous founder experience;
• Deep technical domain experience in fibrotic disease biology and/or clinical development;
• First-hand experience with pre-clinical fibrosis models, primary human in vitro systems, and familiarity with gold standard methods/assays/readouts;
• Experience effectively integrating bioinformatics platforms into drug development projects;
• Track record of high quality publications or thought leadership in the field;
• Experience of building and leading teams;
• Track record of successful fundraising (dilutive or non-dilutive).

Benefits

By joining DSV, you’ll be joining a team of operators who have founded companies and led translation of science at some of the most respected universities, charities, funds and government agencies. 2/3 of the team have founded or led a company at C-suite and 65% have a PhD. Our team dedicate several hours every week to each Founder or founding team to provide tailored guidance, resources and feedback covering every aspect of what it takes to successfully launch a new venture from both the tech and commercial perspectives:

• We provide optimised, purpose-built, proprietary tools, resources and processes to help create high-impact ventures from scratch, using our venture creation methodology .
• General Inception’s extensive network (investors, clinicians, academics), technical domain expertise, and wide-ranging portfolio company capabilities across tools, platforms, diagnostics and therapeutics.
• DSV’s network of Partners, Advisors, Community and Pharma Scientific Advisory Board members – including leaders of therapeutics VCs, Pharma BD execs, C-suite operators at leading biotech companies, venture builders, and CDMOs, from whom you will receive detailed feedback.
• We jointly provide £250k investment governed by our Investment Committee to incorporate the new venture and develop early proof-of-concept data that’s needed to attract high profile non-venture studio VCs. This funding is also key to get grant funding, which most often needs to be matched with private investment.
• We provide guaranteed income of £4,166 per month paid to each Founder as a fixed consultancy fee until the company is launched and the pre-seed investment is secured.
• You and your co-founder(s) will own a significant equity stake in the company.
• We provide continuous support post spin-out, including fundraising, commercial partnerships, recruitment and team-building (amongst other things). 
• There are dozens of Founders currently at DSV across sectors working collaboratively and supporting one another - a unique resource to draw on.

This is an open application for expressions of interest. Hiring for the role will begin in Q3 2024.

Join Us as a Founder in Residence Climate

We're on the lookout for entrepreneurial individuals with technical and commercial domain expertise with keen interest in founding, and building a global scale, impact driven, high growth company from ground up (full-time).

We are seeking applications from experienced industry, startup and/or new science or engineering based technology development professionals from anywhere in the world to work with us on methane removal from air.

You’ll work closely with the DSV team and the current Founder in Residence for this area to co-found and spin-out a new company. Once the new venture is incorporated with pre-seed investment from DSV, you and your co-founders will own the majority stake in the business and continue receiving support from the DSV team post-spinout.

The role is full-time and fully remote until venture incorporation and spin-out (circa spring/summer 2025). 

The Opportunity

Methane is a powerful greenhouse gas, with around 80 x the warming potential of carbon dioxide over a 20-year timescale. Year-on-year increases in the atmospheric concentration of methane, driven by anthropogenic activities and by the effect of a warming climate on natural systems, are responsible for around 30% of the current rise in global temperature.

If methane could be removed from the air within emissions plumes, or from air in the ambient atmosphere, it might be possible to slow or reverse the trend of increasing methane concentrations. To date, key technical and commercial constraints have limited progress towards this target: atmospheric concentrations of methane are extremely low (2 ppm), methane emissions plumes (while higher in concentration) are distributed over disparate sources, and current measurement capabilities are often insufficient to verify offsetting activities. 

A technology that can effectively remove methane from atmospheric or emissions-plume air must therefore be implementable at low concentrations, across multiple sources, and must be verifiable. If these requirements can be met, the resulting technology would transform our ability to remove methane from air, and by extension our ability to limit further temperature rise related to methane.

Our Approach

Using DSV’s unique scoping methodology, we have begun to systematically map the solution space to identify technologies capable of removing methane from atmospheric or emissions-plume air. This mapping identifies the principle constraints holding back current approaches to methane - concentration, diverse sources, and verification - and, through first-principles thinking, converts these constraints into spaces for radical new innovation.

Requirements

Who Should Apply

Most suitable candidates will likely meet most of the following criteria:

• PhD or equivalent industry R&D know-how focused on: inorganic/physical chemistry; physics; environmental, chemical or mechanical engineering; materials science; atmospheric (geo)chemistry; or similar;
• Broad understanding of current approaches and state-of-the-art (SOTA) technologies, and constraints relevant for this opportunity area;
• Previously led or managed commercial delivery of an innovative biotech, engineering, industrial, or hardware technology venture with broad understanding of technical product development and R&D commercialisation;
• Industry-specific know-how and commercial knowledge (e.g. forming strategic partnerships, industrial value chains, procurement, etc.) relevant for this opportunity area;
• Experience in startup ecosystems and fundraising (via venture capital, private equity, grants or funds);
• Strong entrepreneurial mindset with the ability to translate scientific discoveries into commercial opportunities, ideally with experience conducting techno-economic analyses and market assessments;
• Experience of working in a leadership role, applying project management and collaborative skills with colleagues across different teams.

Benefits

Our Offer

By joining DSV, you will be part of a team of operators who have founded companies and led the translation of science at some of the most respected universities, charities, funds, and government agencies. Here’s what we offer:

• Access to optimised, purpose-built, proprietary tools, resources, and processes to help create high-impact ventures from scratch;
• Opportunity area-specific know-how from our network of Partners and Advisors;
• Up to £250k in investment to incorporate the new venture and develop early proof-of-concept data;
• Guaranteed income of £4,166 per month paid as a consultancy fee until the company is launched and the pre-seed investment is secured;
• Majority equity stake in the new company for you and your co-founders;
• Continuous post-spinout support, including fundraising, commercial partnerships, recruitment, and team-building;
• Collaborative support from dozens of Founders currently at DSV across sectors.

About DSV

Deep Science Ventures is creating a future in which both humans and the planet can thrive.

We use our unique venture creation process to create, spin-out and invest into science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures.

We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions.

This opportunity is funded by the Grantham Foundation, a 501(c)(3) private foundation whose mission is to protect and conserve the natural environment. The Grantham Foundation communicates the risks of climate change and environmental degradation, builds collaboration and alliances between like-minded groups and individuals, and invests in philanthropic and entrepreneurial missions to create new climate solutions.

Rapid Resourcing Ltd are an independent Recruitment Agency looking to expand our current client base.

Hours of work Monday - Friday 08:00-17:00

The role will involve generating new client leads from various sources , including cold calling and door to door sales.

Key Responsibilities

• Strategy Development:

  Create and implement business plans, sales strategies, and growth initiatives to expand the company's customer base and market share.

• Client & Partner Relationship Management:

  Build and maintain strong, long-term relationships with new and existing clients, partners, and industry stakeholders.

• Sales and Pitching:

  Proactively identify potential leads, present company products and services, and create compelling proposals to meet prospective clients' needs.

• Negotiation and Closing Deals:

  Negotiate contracts and pricing agreements to secure new business and achieve revenue targets.

• Identify Growth Opportunities:

  Conduct market research to find new business areas, customer needs, and strategic partnerships.

Skills required are

• Previous sales experience

• Strategic thinking and analytical abilities.

• Excellent communication, negotiation, and interpersonal skills.

Advantage would be experience in the Industrial Recruitment sector

At Blue Arrow, we're redefining the world of recruitment. We don't simply hire recruitment consultants, we invest in Recruitment Superheroes with a passion for people and purpose and ambitions of progression, rewards and so much more.

We have been named as a Financial Times Diversity Leader, awarded Best Companies three-star rating, the highest possible level representing organisations that excel at world class levels of workplace engagement, and we continue to be an Investors in People Platinum employer - the highest accolade that can be achieved. Making Blue Arrow a truly great place to work.

At Blue Arrow, we genuinely care about creating a diverse and inclusive team, not just because it's the right thing to do, but because we know it makes us a stronger, better business. We are searching for people that share our excitement and passion for what we do, and we will continue to grow our #OneBlueFamily with brilliant people from all different backgrounds, perspectives, and experiences, celebrating our differences and knowing that collectively we make the difference.

We're a team of high-achievers we're also parents, mentors, gym-goers, animal-lovers, bakers, music-lovers and so much more. We're Blue Arrow, and we're dedicated to Enhancing Your Everyday with our people-first priorities, Progression, Purpose, Teamwork, Rewards and Performance.

Sounds like something you'd like to be part of, have a passion for sales and ready for your next career move ?

Join our #OneBlueFamily Newbury branch team as a Senior Recruitment Consultant (Executive or Principle) with a focus on business development growing a desk supplying permanent and temporary staff to clients across all sectors.

You will be supported by our advanced technology systems, and we embrace hybrid working offering our people the flexibility to work from home for a proportion of their week. We are also committed to maximising wellbeing which is why we have a dedicated Out of Hours service that can support our Operational teams when it's time to relax.

Some of your day-to-day responsibilities as a Recruitment Consultant will include:

• Growing business opportunities with existing and new clients
• Identifying sales leads and making business to business outbound sales calls to bring in new roles and bookings
• Developing client and candidate relationships
• Sales and marketing activities, working to targets
• Travelling to visit clients for meetings so you will ideally need to be a driver and have access to your own car
• Sourcing and recruiting staff for permanent vacancies and bookings
• Negotiating, offering solutions and overcoming objections

Blue Arrow is a leading global Talent Acquisition and Managed Workforce Solutions provider. Blue Arrow specialises in staffing for Admin & Secretarial including Call Centre, Transport & Logistics, Hospitality & Catering, Manufacturing & Production and Public Sector.

Some of the Benefits, Training and Development we offer:

• Hybrid working in the Newbury office and from home

• Salary basic up to 33k basic + uncapped bonus

• Performance based quarterly salary reviews and clear career path
• Dedicated structured support for new starters, including performance and development support, goal setting and advice on navigating your way through your new job
• 25 days holiday (plus public holidays) increasing by length of service until it reaches 30 days
• Focused wellbeing programme, including access to a network of mental health first aiders and a full subscription to the Calm mindfulness app
• Your Birthday off and you can buy extra holidays
• Fully paid day off for charity work of your choice
• Wide range of flexible and lifestyle benefits
• Long service and recognition awards
• Ongoing training and development
• Opportunity to enjoy trips for Gold Award Winners
• Very experienced Branch Manager and team of colleagues

Proud to be an inclusive and equitable employer:

We are committed to being a Disability Confident Employer. Therefore, we strongly encourage applications from candidates with a disability and commit to interview these candidates if their application meets the minimum criteria for the role - just tell us when applying.

We are also a forces-friendly employer and extend the same interview guarantee to any current reservists, ex-armed forces personnel or forces spouses/partners applying.

To ensure you have the best experience with us, please let us know if we can make any adjustments to our application or interview process and feel free to note in your application which pronouns you use.

We consider ourselves to be an equitable employer which celebrates diversity and encourages inclusion. Our ongoing commitments to Equality, Equity, Diversity and Inclusion means we recognise candidates may want to anonymise their cv during the application process, if you wish to do this, you are welcome to do so.

RSS Global is a portfolio of brands specialising in staffing and workforce solutions in the UK, Ireland and Asia Pacific. Our brands include Blue Arrow, Chadwick Nott, Global Medics, Litmus, Medacs Healthcare, Tate and The Recruitment Co.

Please see our privacy notice and note all data processing will be in line with our privacy notice that you can view by clicking here (url removed)>